US Patent

US8093297 — Methods for concomitant administration of colchicine and a second active agent

Method of Use · Assigned to Mutual Pharmaceutical Co Inc · Expires 2028-10-06 · 2y remaining

Vulnerability score 80/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods for safely administering colchicine with one or more additional active agents, such as ketoconazole and ritonavir.

USPTO Abstract

Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for concomitant administration of colchicine together with second active agents are also provided.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-1161 — Colcrys

Patent Metadata

Patent number
US8093297
Jurisdiction
US
Classification
Method of Use
Expires
2028-10-06
Drug substance claim
No
Drug product claim
No
Assignee
Mutual Pharmaceutical Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.